Wu H, Pelkonen E, Knuutila S, Kaartinen M
Department of Bacteriology and Immunology, University of Helsinki, Finland.
Eur J Immunol. 1995 Dec;25(12):3263-9. doi: 10.1002/eji.1830251210.
The functional immunoglobulin (Ig) genes of B lymphocytes undergo somatic mutations during immune responses. These mutations modify the antigen binding site of the immunoglobulins, thereby enhancing the average affinity of the antibodies produced. The molecular mechanism underlying these B cell hypermutations remains unresolved, partly because it is difficult to grow normal B cells in long-term cell cultures and because there is no suitable transformed or malignant B cell line which generates mutations in its immunoglobulin genes in vitro. Here, we show that the recently established follicular lymphoma line HF-1.3.4 generates somatic hypermutations in vitro at a high frequency of 0.7 x 10(-6) mutations per base pair per generation in standard cell cultures (RPMI 1640 + 5% fetal calf serum). This shows for the first time that B cell hypermutation can occur without T cells or T cell factors. The mutation frequency increased approximately tenfold to 1 x 10(-5) mutations/base pair/generation with B cell-specific growth factors (interleukins-2 and -4 and three antibodies stimulatory to HF-1.3.4 cells). This HF-1.3.4 lymphoma line may help to elucidate the molecular mechanism of Ig gene hypermutation.
B淋巴细胞的功能性免疫球蛋白(Ig)基因在免疫反应过程中会发生体细胞突变。这些突变会改变免疫球蛋白的抗原结合位点,从而提高所产生抗体的平均亲和力。这些B细胞超突变背后的分子机制仍未得到解决,部分原因是在长期细胞培养中难以培养正常B细胞,且没有合适的转化或恶性B细胞系能在体外其免疫球蛋白基因中产生突变。在此,我们表明,最近建立的滤泡性淋巴瘤细胞系HF-1.3.4在标准细胞培养条件(RPMI 1640 + 5%胎牛血清)下,体外以每代每碱基对0.7×10⁻⁶个突变的高频产生体细胞超突变。这首次表明B细胞超突变可以在没有T细胞或T细胞因子的情况下发生。使用B细胞特异性生长因子(白细胞介素-2和-4以及三种对HF-1.3.4细胞有刺激作用的抗体)时,突变频率增加约十倍,达到1×10⁻⁵个突变/碱基对/代。这个HF-1.3.4淋巴瘤细胞系可能有助于阐明Ig基因超突变的分子机制。